In a Phase 2 randomised controlled trial published in the New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), adults with obesity (without type 2 diabetes) who received the highest dose of retatrutide (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks
Our dedicated longevity experts are available to answer your questions
But not all GLP-1s affect people the same way
After complete surgical excision, the local-regional relapse rate is reported to be 10-20%, and 5-year survival rates are clustered around 10-25%, with a reported range of 4.5-48%
Why Our Gel Outperforms Oral Supplements Most oral joint supplements get diluted and weakened as they pass through your digestive system, spreading throughout your entire body instead of targeting your pain
Do note that GLP-1 medicines are not currently licensed for reproductive health, including the treatment of PCOS